Novel and Specific Respiratory Syncytial Virus Inhibitors That Target Virus Fusion

This publication has 8 references indexed in Scilit:

• Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro : Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant
  Proceedings of the National Academy of Sciences, 1997
• Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection
  The Pediatric Infectious Disease Journal, 1997
• Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation
  Antimicrobial Agents and Chemotherapy, 1996
• Respiratory Syncytial Virus Is an Important Cause of Community-Acquired Lower Respiratory Infection among Hospitalized Adults
  The Journal of Infectious Diseases, 1996
• Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections
  International Journal of Antimicrobial Agents, 1996
• Post-translational Processing and Oligomerization of the Fusion Glycoprotein of Human Respiratory Syncytial Virus
  Journal of General Virology, 1991
• From the National Institute of Allergy and Infectious Diseases and the World Health Organization: Respiratory Syncytial and Parainfluenza Viruses
  The Journal of Infectious Diseases, 1990
• Towards the development of antimicrobial drugs acting by inhibition of pathogen attachment to host cells: A need for polyvalency
  FEBS Letters, 1989